RxDoctor Payments Data

Terra Wadley, APRN

Gerontology · Lexington, KYNPI 1578100384

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 29 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Organogenesis Inc. accounts for 75.4% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2024 at $225 and has fallen 56.7% since, to $97 in 2025.

$675in general payments, 2019–2025

Across 29 payments — averaging $23.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$509
  • Nevro Corp.$150
  • Medtronic$16

What the payments were for

  • Food & beverage$675100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Organogenesis Inc.26$509
Nevro Corp.2$150
Medtronic1$16

How this compares

$675 in reported general payments places this provider in the 60th percentile of 84 gerontology providers in Kentucky.

See all gerontology providers in Kentucky

Medicare billing

Part B allowed, 2024
$454,771
Medicare patients
478
Services billed
3,321

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SantylCollagenase Clostridium Hist.17$27,798

Paid to pharmacies, not to this prescriber.

Other gerontology in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →